FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

21834211000001108: Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Mar 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
72619701000001113 Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
72619801000001116 Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Darunavir true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Darunavir 800mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has AMP Prezista 800mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Darunavir ethanolate false Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir false Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Prezista 800mg tablets (Janssen-Cilag Ltd) 30 tablet Has basis of strength substance Darunavir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start